Intravitreal bevacizumab with or without mitomycin C trabeculectomy in the treatment of neovascular glaucoma
Hatem M Marey, Amin F EllakwaDepartment of Ophthalmology, Faculty of Medicine, Menoufiya University, Shibin el Kom, EgyptPurpose: To demonstrate the role of intravitreal bevacizumab in regression of iris neovascularization, and intraocular pressure (IOP) control in neovascular glaucoma.Methods: A re...
Guardado en:
Autores principales: | Marey HM, Ellakwa AF |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/28e17fb3e26942e3abea696e5ba5f9b9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema
por: Marey HM, et al.
Publicado: (2011) -
Subconjunctival bevacizumab to augment trabeculectomy with mitomycin C in the management of failed glaucoma surgery
por: Saeed AM, et al.
Publicado: (2014) -
Anterior segment changes following intravitreal bevacizumab injection for treatment of neovascular glaucoma
por: Canut MI, et al.
Publicado: (2011) -
Preoperative intravitreal Ranibizumab with panretinal photocoagulation followed by conventional trabeculectomy without drainage device for neovascular glaucoma
por: Xiao-Dong Han, et al.
Publicado: (2021) -
Trabeculectomy versus Ahmed Glaucoma Valve implantation in neovascular glaucoma
por: Christopher C Shen, et al.
Publicado: (2011)